Table: Where Astra Stands In The Global Drug Derby
With just $3.8 billion in sales, Astra is no Goliath. But well-placed research and marketing bets have made it a world leader in painkillers, and one of the fastest-growing drugmakers GLOBAL SHARE DRUG TOP ASTRA MARKET FOR ASTRA CATEGORY DRUG (BILLIONS) DRUGS COMPETITION HYPERTENSION PLENDIL $25 4% Pfizer's Procardia PEPTIC ULCERS LOSEC 10 23 Glaxo's Zantac ASTHMA PULMICORT 5 13 Glaxo's Becotide ANESTHETICS* XYLOCAINE 1 65 Generics DATA: ASTRA, SALOMON BROTHERS INC. *Local
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.